Page last updated: 2024-08-23

ursodeoxycholic acid and Cancer, Second Primary

ursodeoxycholic acid has been researched along with Cancer, Second Primary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Florea, A; Harris, RB; Jacobs, ET; Jurutka, PW; Klimentidis, YC; Kohler, LN1
Hibler, EA; Hu, C; Jacobs, ET; Jurutka, PW; Martinez, ME1

Other Studies

2 other study(ies) available for ursodeoxycholic acid and Cancer, Second Primary

ArticleYear
Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma.
    Journal of gastrointestinal cancer, 2021, Volume: 52, Issue:3

    Topics: Adenoma; Aged; Aged, 80 and over; Arizona; Cholagogues and Choleretics; Clinical Trials, Phase III as Topic; Colonic Polyps; Colorectal Neoplasms; Female; Fibroblast Growth Factors; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Ursodeoxycholic Acid

2021
Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012, Volume: 21, Issue:2

    Topics: Aged; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Dietary Fiber; Double-Blind Method; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Middle Aged; Neoplasms, Second Primary; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid; Vitamin D; Vitamin D-Binding Protein

2012